496 related articles for article (PubMed ID: 33525334)
21. The prion's elusive reason for being.
Aguzzi A; Baumann F; Bremer J
Annu Rev Neurosci; 2008; 31():439-77. PubMed ID: 18558863
[TBL] [Abstract][Full Text] [Related]
22. Manganese upregulates cellular prion protein and contributes to altered stabilization and proteolysis: relevance to role of metals in pathogenesis of prion disease.
Choi CJ; Anantharam V; Martin DP; Nicholson EM; Richt JA; Kanthasamy A; Kanthasamy AG
Toxicol Sci; 2010 Jun; 115(2):535-46. PubMed ID: 20176619
[TBL] [Abstract][Full Text] [Related]
23. Strain-specific prion-protein conformation determined by metal ions.
Wadsworth JD; Hill AF; Joiner S; Jackson GS; Clarke AR; Collinge J
Nat Cell Biol; 1999 May; 1(1):55-9. PubMed ID: 10559865
[TBL] [Abstract][Full Text] [Related]
24. Strain-Dependent Prion Infection in Mice Expressing Prion Protein with Deletion of Central Residues 91-106.
Uchiyama K; Miyata H; Yamaguchi Y; Imamura M; Okazaki M; Pasiana AD; Chida J; Hara H; Atarashi R; Watanabe H; Kondoh G; Sakaguchi S
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019549
[TBL] [Abstract][Full Text] [Related]
25. Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications.
Singh J; Udgaonkar JB
Biochemistry; 2015 Jul; 54(29):4431-42. PubMed ID: 26171558
[TBL] [Abstract][Full Text] [Related]
26. Prion protein and metal interaction: physiological and pathological implications.
Singh N; Das D; Singh A; Mohan ML
Curr Issues Mol Biol; 2010; 12(2):99-107. PubMed ID: 19767653
[TBL] [Abstract][Full Text] [Related]
27. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
Moreno JA; Telling GC
Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
[TBL] [Abstract][Full Text] [Related]
28. The role of rafts in the fibrillization and aggregation of prions.
Pinheiro TJ
Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
[TBL] [Abstract][Full Text] [Related]
29. Modulation of proteinase K-resistant prion protein in cells and infectious brain homogenate by redox iron: implications for prion replication and disease pathogenesis.
Basu S; Mohan ML; Luo X; Kundu B; Kong Q; Singh N
Mol Biol Cell; 2007 Sep; 18(9):3302-12. PubMed ID: 17567949
[TBL] [Abstract][Full Text] [Related]
30. Games played by rogue proteins in prion disorders and Alzheimer's disease.
Aguzzi A; Haass C
Science; 2003 Oct; 302(5646):814-8. PubMed ID: 14593165
[TBL] [Abstract][Full Text] [Related]
31. Prion infection impairs lysosomal degradation capacity by interfering with rab7 membrane attachment in neuronal cells.
Shim SY; Karri S; Law S; Schatzl HM; Gilch S
Sci Rep; 2016 Feb; 6():21658. PubMed ID: 26865414
[TBL] [Abstract][Full Text] [Related]
32. Evolving views in prion glycosylation: functional and pathological implications.
Ermonval M; Mouillet-Richard S; Codogno P; Kellermann O; Botti J
Biochimie; 2003; 85(1-2):33-45. PubMed ID: 12765773
[TBL] [Abstract][Full Text] [Related]
33. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
34. Prion protein aggregation and fibrillogenesis in vitro.
Stöhr J
Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001
[TBL] [Abstract][Full Text] [Related]
35. Copper binding to the PrP isoforms: a putative marker of their conformation and function.
Shaked Y; Rosenmann H; Hijazi N; Halimi M; Gabizon R
J Virol; 2001 Sep; 75(17):7872-4. PubMed ID: 11483731
[TBL] [Abstract][Full Text] [Related]
36. Clustering of sialylated glycosylphosphatidylinositol anchors mediates PrP-induced activation of cytoplasmic phospholipase A 2 and synapse damage.
Bate C; Williams A
Prion; 2012; 6(4):350-3. PubMed ID: 22895089
[TBL] [Abstract][Full Text] [Related]
37. The role of lipid rafts in prion protein biology.
Lewis V; Hooper NM
Front Biosci (Landmark Ed); 2011 Jan; 16(1):151-68. PubMed ID: 21196164
[TBL] [Abstract][Full Text] [Related]
38. Strain Typing of Prion Diseases Using In Vivo Mouse Models.
Boyle A; Hogan K; Manson JC; Diack AB
Methods Mol Biol; 2017; 1658():263-283. PubMed ID: 28861795
[TBL] [Abstract][Full Text] [Related]
39. Prion protein-Semisynthetic prion protein (PrP) variants with posttranslational modifications.
Hackl S; Becker CFW
J Pept Sci; 2019 Oct; 25(10):e3216. PubMed ID: 31713950
[TBL] [Abstract][Full Text] [Related]
40. Copper binding to PrPC may inhibit prion disease propagation.
Hijazi N; Shaked Y; Rosenmann H; Ben-Hur T; Gabizon R
Brain Res; 2003 Dec; 993(1-2):192-200. PubMed ID: 14642846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
